Related Experiment Video

Updated: Jul 1, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

16.9K

Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges

Manuela Mandorino1, Ahana Maitra1, Domenico Armenise1

  • 1Research Laboratory for Woman and Child Health, Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Cancers
|May 25, 2024
PubMed

Insights

Diffuse midline glioma (DMG), a pediatric brain cancer, is driven by the H3K27M mutation affecting histone genes. This mutation disrupts brain development and stem cell function, highlighting the need for new treatments.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Developmental Neuroscience

Background:

  • Diffuse intrinsic pontine glioma (DIPG), now diffuse midline glioma (DMG), is an aggressive pediatric brain cancer with no effective treatments.
  • DMG predominantly affects children aged 4-9, impacting deep midline brain structures and suggesting links to epigenetic regulation in early development.
  • The H3K27M mutation in histone genes is a known driver, but its precise role in tumor initiation and progression remains unclear.

Purpose of the Study:

  • To review the literature on diffuse midline glioma (DMG) and the H3K27M mutation.
  • To explore the connection between H3K27M mutations, epigenetic dysregulation, and pediatric brain tumor development.
  • To understand the impact of H3K27M on neural progenitor cells and brain development pathways.

Main Methods:

  • Comprehensive literature review of studies on DIPG/DMG and H3K27M mutations.
  • Analysis of genomic data regarding H3 gene family expression in the developing brain.
  • Examination of the functional consequences of H3K27M on cellular processes like proliferation and differentiation.

Main Results:

  • Over 85% of DMG tumors harbor the H3K27M mutation in histone H3.3 or H3.1 genes.
  • This mutation leads to aberrant gene expression, promoting tumor growth and metastasis.
  • H3K27M impacts critical developmental pathways, including epithelial-mesenchymal transition (EMT), and disrupts stem cell proliferation and differentiation.

Conclusions:

  • The H3K27M mutation is a key factor in DMG pathogenesis, affecting crucial brain development processes.
  • Understanding the developmental origins and epigenetic mechanisms of DMG is essential for developing targeted therapies.
  • Further research is needed to elucidate the full impact of H3K27M and to identify effective treatment strategies for this devastating pediatric cancer.

Keywords:
H3K27-alteredbrain developmentdiffuse intrinsic pontine glioma (DIPG)neonatal

More Related Videos

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.5K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...